Number of products required for bio-equivalency tests to readjust.

The revised pharmaceutical affairs law allows pharmacists to dispense prescription drugs for other substitutive analogues only within the category of biological preparations. Accordingly, the products required for the biological equivalent tests in verifying its efficacy equivalency to the original drugs should be reasonably readjusted.

Furthermore, the new provision facilitates establishmen...